CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,000 | 0.0% | 54,063 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -32.3% | 54,063 | 0.0% | 0.00% | – |
| Q3 2021 | $65,000 | -89.7% | 54,063 | -86.7% | 0.00% | – |
| Q2 2021 | $629,000 | -48.3% | 405,290 | -20.0% | 0.00% | – |
| Q1 2021 | $1,217,000 | -14.1% | 506,726 | +5.5% | 0.00% | -100.0% |
| Q4 2020 | $1,417,000 | +96.3% | 480,106 | +1.7% | 0.00% | – |
| Q3 2020 | $722,000 | -13.7% | 471,893 | +40.9% | 0.00% | – |
| Q2 2020 | $837,000 | +34.6% | 334,796 | +9.8% | 0.00% | – |
| Q1 2020 | $622,000 | -33.0% | 304,894 | +1.4% | 0.00% | – |
| Q4 2019 | $929,000 | +1.6% | 300,542 | +9.9% | 0.00% | -100.0% |
| Q3 2019 | $914,000 | -8.9% | 273,569 | -12.7% | 0.00% | 0.0% |
| Q2 2019 | $1,003,000 | +37.6% | 313,252 | +23.4% | 0.00% | – |
| Q1 2019 | $729,000 | -33.7% | 253,751 | -7.2% | 0.00% | -100.0% |
| Q4 2018 | $1,100,000 | -14.9% | 273,396 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $1,293,000 | +51.1% | 276,711 | +166.2% | 0.00% | 0.0% |
| Q2 2018 | $856,000 | – | 103,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |